SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Additional Listing

4 Nov 2011 07:00

RNS Number : 4593R
BowLeven Plc
04 November 2011
 

 

 

 

 

 

 

 

 

4 November 2011

 

Bowleven plc ("Bowleven" or the "Company")

 

 

Admission of Shares to AIM

 

Application has been made for the admission of 77,500,000 new ordinary shares (the "Shares") of 10p each in the capital of Bowleven to trading on AIM. The Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of 10 pence each in the capital of the Company, including the right to receive all dividends and other distributions declared, made or paid on or in respect of such shares after the date of issue of the Shares.

 

These shares are being listed in connection with the issue of equity announced on 19 October 2011.

 

 

ENQUIRIES

 

For further information please contact:

 

Bowleven 00 44 131 524 5678

Kevin Hart, Chief Executive Officer

Kerry Crawford, Head of Investor Relations

 

Brunswick Group LLP 00 44 207 404 5959

Patrick Handley

Natalia Erikssen

 

BofA Merrill Lynch 00 44 207 628 1000

Andrew Osborne

Tony White

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISBJBJTMBAMBRB
Date   Source Headline
8th Dec 202111:53 amRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20217:00 amRNSPosting of Annual Report and Accounts 2021
10th Nov 202111:05 amRNSSecond Price Monitoring Extn
10th Nov 202111:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSFull Year Results
9th Nov 20218:55 amRNSBlock Admission Six Monthly Return
20th Aug 20214:41 pmRNSSecond Price Monitoring Extn
20th Aug 20214:36 pmRNSPrice Monitoring Extension
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn
20th Aug 20212:00 pmRNSPrice Monitoring Extension
20th Aug 202111:05 amRNSSecond Price Monitoring Extn
20th Aug 202111:00 amRNSPrice Monitoring Extension
20th Aug 20219:05 amRNSSecond Price Monitoring Extn
20th Aug 20219:00 amRNSPrice Monitoring Extension
24th May 20212:06 pmRNSSecond Price Monitoring Extn
24th May 20212:00 pmRNSPrice Monitoring Extension
14th May 202111:05 amRNSSecond Price Monitoring Extn
14th May 202111:00 amRNSPrice Monitoring Extension
13th May 202111:06 amRNSSecond Price Monitoring Extn
13th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:15 amRNSBlock Admission Six Monthly Return
30th Mar 20212:05 pmRNSSecond Price Monitoring Extn
30th Mar 20212:01 pmRNSPrice Monitoring Extension
30th Mar 20219:05 amRNSSecond Price Monitoring Extn
30th Mar 20219:00 amRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSInterim Results
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
3rd Mar 20217:00 amRNSHolding(s) in Company
12th Feb 202111:06 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
27th Jan 20215:50 pmRNSTR-1: Notification of major holdings
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSEtinde Exploitation Authorisation Agreement
11th Jan 20217:00 amRNSAppointment of Chairman
31st Dec 202012:35 pmRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:36 pmRNSPrice Monitoring Extension
17th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 202011:06 amRNSResult of Annual General Meeting
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
24th Nov 20204:40 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.